Trading Concept
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
No Result
View All Result
Trading Concept
No Result
View All Result
Home Trading News

Pfizer submits FDA application for emergency approval of Covid treatment pill

by
November 16, 2021
in Trading News
0
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

RELATED POSTS

The bull case for Saudi Arabia stocks is growing, but risks remain

Crypto bill from Republicans lays out clear roles for SEC and CFTC

Pfizer CEO Albert Bourla addresses a press conference after a visit to oversee the production of the Pfizer-BioNtech COVID-19 vaccine at the factory of U.S. pharmaceutical company Pfizer in Puurs, Belgium April 23, 2021.

John Thys | Pool | Reuters

Pfizer on Tuesday submitted its application to the Food and Drug Administration for emergency authorization of its Covid-19 treatment pill, saying it reduces hospitalization and death by 89% when administered with a common HIV drug.

The pill, if authorized by the FDA, could help revolutionize the fight against Covid by allowing high-risk people infected with the virus to take an oral anti-viral drug at home instead of going to the hospital. Such a treatment could help reduce the strain that has been put on hospital systems during the pandemic.

In a clinical trial of people 18 and over at an increased risk of developing severe Covid, the pill reduced hospitalization and death by 89% when taken within three days of the onset of symptoms, according to Pfizer.

The pill, known as Paxlovid, blocks the activity of an enzyme the virus needs to replicate. Paxlovid is used in combination with a low-dose of ritonavir, an HIV drug, to slow the patient’s metabolism, allowing the drug to remain active in the body at a higher concentration for a longer period to combat the virus.

Pfizer said the Covid treatment proved to be safe, adding that there were fewer adverse events reported by trial participants who took Paxlovid than the placebo, and most of those were “mild in intensity.”

If approved, Paxlovid will be administered in two 150 mg tablets along with one 100 mg tablet of ritonavir twice daily.

“We are moving as quickly as possible in our effort to get this potential treatment into the hands of patients, and we look forward to working with the U.S. FDA on its review of our application, along with other regulatory agencies around the world,” Pfizer CEO Albert Bourla said in a statement Tuesday.

Bourla had previously said that Pfizer planned to submit its data to the FDA before Thanksgiving.

Earlier Tuesday, Pfizer announced that it would allow generic manufacturers to supply its antiviral pill to 95 low and middle-income countries.

Merck is also developing an antiviral pill, Molnupiravir, to combat Covid. The company found in an interim analysis that the pill reduced the risk of hospitalization and death by 50% in adults with mild to moderate Covid.

Merck, which developed the drug with Ridgeback Biotherapeutics, submitted its application to the FDA last month for the pill to receive emergency authorization.

This is breaking news. Please Check back for updates.

ShareTweetPin

Related Posts

The bull case for Saudi Arabia stocks is growing, but risks remain

by
June 2, 2023
0

There's a burgeoning bull case for Saudi Arabia stocks. The iShares MSCI Saudi Arabia ETF (KSA) is up more than...

Crypto bill from Republicans lays out clear roles for SEC and CFTC

by
June 2, 2023
0

Rep. Patrick McHenry, a Republican of North Carolina and ranking member of the House Financial Services Committee, speaks during a...

Google says Gmail on your phone just got a lot faster thanks to A.I.

by
June 2, 2023
0

In this article GOOGL Follow your favorite stocksCREATE FREE ACCOUNT Sundar Pichai, CEO, Alphabet Inc., during the Google I/O developers...

How Nvidia’s rise has changed the biggest momentum ETF

by
June 2, 2023
0

The excitement around artificial intelligence that sent Nvidia and a few other tech stocks soaring in the first half of...

West Coast ports shut down as union workers ‘no show’ after breakdown in wage negotiations

by
June 2, 2023
0

West Coast ports are shutting down as union workers "no show" after a breakdown in negotiations with port management. The...

Next Post

November 16th COVID-19: New Cases Increasing, Above 83K per Day

EV start-up Lucid's market value blows past Ford at more than $89 billion as shares skyrocket

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

email

Get the daily email about stock.

Please Enter Your Email Address:



By opting in you agree to our Privacy Policy. You also agree to receive emails from us and our affiliates. Remember that you can opt-out any time, we hate spam too!

MOST VIEWED

  • WHO says Covid vaccine booster programs will prolong pandemic

    0 shares
    Share 0 Tweet 0
  • Forget Tesla — this auto stock is the one to buy right now, analyst says

    0 shares
    Share 0 Tweet 0
  • Spin or Split? AT&T Has a Big Decision to Make on Discovery Stake.

    0 shares
    Share 0 Tweet 0
  • Here’s how Carl Icahn is positioning for a possible recession in America

    0 shares
    Share 0 Tweet 0
  • Some lawmakers and their families are betting thousands of dollars on crypto

    0 shares
    Share 0 Tweet 0
  • Home
  • Trading News
  • Email Whitelisting
  • Privacy Policy
All rights reserved by tradingconcept.net
No Result
View All Result
  • Email Whitelisting
  • Home
  • Privacy Policy

All rights reserved by www.tradingconcept.net